Aug 11, 2022
Bijan Esfandiari serves as Senior shareholder at Baum Hedlund Aristei & Goldman, litigating cases of pharmaceutical product liability. Bijan discusses his current MDL (No. 3036) against pharmaceutical company Merck for the production and distribution of Gardasil, an HPV vaccine believed to cause POTS. Esfandiari explains how the defense shames victims of the toxic vaccine into silence by labeling them “anti-vaxers.” Esfandiari also actively worked on the 2010 GlaxoSmithKline (GSK) litigation, which resulted in $750 million settlement in civil and criminal claims over the company’s manufacturing of contaminated medication. Esfandiari received a unanimous agreement from a three-judge panel for his arguments in both the McCormick v. Medtronic, Inc. and Mason v. SmithKline Beecham Corp.
With over 20 years of experience in law, Esfandiari holds great passion for helping others, specifically those harmed by large corporations. Bijan’s most recent honors include being named to the 2022 of Best Lawyers in America®, Lawdragon’s 2022 list of Leading Plaintiff Consumer Lawyers, and Law360’s 2021 series of Regional Powerhouses in California. Bijan also received recognition on the Southern California Super Lawyers® list of Rising Stars annually since 2009. Esfandiari remains active in the law community outside of the courtroom by speaking at national law conferences. Bijan maintains membership in the American Association for Justice’s Leader’s Forum, the Consumer Attorneys Association of Los Angeles, and UCLA Journal of International Law & Foreign Affairs. Bijan speaks fluent Farsi and conversational German.
Remember to subscribe and follow us on social media…
LinkedIn: https://www.linkedin.com/company/mass-tort-news